LOSARTAN POTASSIUM

Manufacturer: DirectRX
Effective date: 2015-12-03
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 20:21:36

Label at a glance#

ProductLOSARTAN POTASSIUM

Active ingredientLOSARTAN POTASSIUM

Label structure3 sections

Boxed warning

fetal toxicity When pregnancy is detected, discontinue losartan potassium tablets as soon as possible. Drugs that act directly on the rennin-angiotensin system can cause injury and death to the developing fetus. See WARNINGS, Fetal Toxicity.

Label contents#

Full prescribing information#

Boxed Warning

BOXED WARNING SECTION

fetal toxicity

When pregnancy is detected, discontinue losartan potassium tablets as soon as possible.
Drugs that act directly on the rennin-angiotensin system can cause injury and death to the developing fetus. See WARNINGS, Fetal Toxicity.

Clinical Pharmacology

CLINICAL PHARMACOLOGY SECTION

Clinical Pharmacology Continued

CLINICAL PHARMACOLOGY SECTION

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
979485	losartan potassium 25 MG Oral Tablet	PSN	1
979485	losartan potassium 25 MG Oral Tablet	SCD	1
979485	Losartan K+ 25 MG Oral Tablet	SY	1
979485	Losartan Pot 25 MG Oral Tablet	SY	1

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
LOSARTAN Pharmacologic Class Indexing	4	Indexing - Pharmacologic Class	20230503

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
0d341e63-aee5-498b-bf9a-b53a43963acf	Product name	1	20260105
de29c5c0-90ba-29da-d7ab-0500274708be	Product name	6	20241009
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61919-461-30	2020-01-31	C162847	48780-1	9d75b9cf-fbb4-f424-e053-dadaa90a57ce	LOSARTAN POTASSIUM

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61919-461-30	LOSARTAN POTASSIUM	30 in 1 BOTTLE	TABLET	30		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61919-461	LOSARTAN POTASSIUM TABLET [DIRECTRX]	1	Legacy NDC, 1 package rows	20151203_25fe6b18-e408-4b17-e054-00144ff8d46c.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61919-461-30	EA - Each	61919-461	a4685dea-9daf-4986-acb4-a9eaaf3d1ecd	1	2016-02-04
61919-461-90	EA - Each	61919-461	ce1b2264-6c6c-4c9d-ac9b-74f3727a8d8d	1	2019-08-06
13668-113-10	EA - Each	13668-113	4281caf0-540c-400b-b4f7-8a0478c7117f	1	2012-07-24
13668-113-90	EA - Each	13668-113	049c3384-5851-4fa9-8c45-2b83fe64ed68	1	2012-07-24

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

LOSARTAN POTASSIUM
CELLULOSE, MICROCRYSTALLINE
HYDROXYPROPYL CELLULOSE (TYPE H)
HYPROMELLOSE 2910 (6 MPA.S)
ANHYDROUS LACTOSE
LOSARTAN
COLLOIDAL SILICON DIOXIDE
MAGNESIUM STEARATE
STARCH, PREGELATINIZED CORN
TALC
TITANIUM DIOXIDE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
61919-461	61919-461-30
13668-113

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
HYDROXYPROPYL CELLULOSE (TYPE H)	RFW2ET671P	IACT
HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	IACT
ANHYDROUS LACTOSE	3SY5LH9PMK	IACT
LOSARTAN POTASSIUM	3ST302B24A	ACTIB
COLLOIDAL SILICON DIOXIDE	ETJ7Z6XBU4	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
STARCH, PREGELATINIZED CORN	O8232NY3SJ	IACT
TALC	7SEV7J4R1U	IACT
TITANIUM DIOXIDE	15FIX9V2JP	IACT

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A090467-001	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06
A090467-002	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06
A090467-003	LOSARTAN POTASSIUM	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090467-002	LOSARTAN POTASSIUM	50MG	TABLET / ORAL	2010-10-06	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A090467-003	LOSARTAN POTASSIUM	100MG	TABLET / ORAL	2010-10-06	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A090467-001	LOSARTAN POTASSIUM	25MG	TABLET / ORAL	2010-10-06	`301d65b070ca…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	A090467-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090467-002	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A090467-003	AB	1	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	A090467-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A090467-002	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A090467-003	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A090467-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A090467-002	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A090467-003	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A090467-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A090467-002	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A090467-003	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A090467-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A090467-002	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A090467-003	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A090467-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A090467-002	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A090467-003	AB	1	`ea99ee380514…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
25fe6b18-e409-4b17-e054-00144ff8d46c			25fe6b18-e408-4b17-e054-00144ff8d46c	2015-12-03	Boxed warning, Warnings, Adverse reactions	Exact identifier spl id: 25fe6b18-e409-4b17-e054-00144ff8d46c spl set id: 25fe6b18-e408-4b17-e054-00144ff8d46c

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.